SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-006840
Filing Date
2023-02-02
Accepted
2023-02-01 20:00:32
Documents
14
Period of Report
2023-02-01
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea172575-8k_biotech.htm   iXBRL 8-K 35755
2 PRESS RELEASE, DATED AS OF FEBRUARY 1, 2023 ea172575ex99-1_biotech.htm EX-99.1 7214
  Complete submission text file 0001213900-23-006840.txt   275137

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE biotu-20230201.xsd EX-101.SCH 4332
4 XBRL DEFINITION FILE biotu-20230201_def.xml EX-101.DEF 27229
5 XBRL LABEL FILE biotu-20230201_lab.xml EX-101.LAB 37727
6 XBRL PRESENTATION FILE biotu-20230201_pre.xml EX-101.PRE 25849
8 EXTRACTED XBRL INSTANCE DOCUMENT ea172575-8k_biotech_htm.xml XML 6995
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 23578403
SIC: 6770 Blank Checks